Investify – July Stock 2021

July Stock 2021

Published on July 2021

Our “July Company Profile” Pacific Edge Limited had a very positive FY20 reporting 76% revenue growth and announcing commercial prospects in the US. The share price growth for 2019-20 was 289% and currently 2 Analysts following the stock predict a 12 month target price of $1.50. Pacific Edge Limited engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. The company was founded on February 27, 2001 and is headquartered in Dunedin, New Zealand.

Share this article with a friend!

Kickstart your mate's investing game.

Investify Limited is an information service provided on an “as is” and “as available” basis. We do not provide advice and do not make recommendations. We are a research tool for self-directed investors, individual investment advisors and financial institutions. Please read our terms of service. Please be advised that Investify Limited is in no way associated or connected to Investify SA and Investify PK. We are based in New Zealand.

End-of-day pricing data, fundamentals, aggregated analyst recommendations and estimates are provided by Factset UK Limited.

Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. Before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

Investify is NOT a Data Provider neither we create any data within our systems which will make it the golden source. For all the analytical insights generated by Investify the data source can be traced to the raw data supplied by our data suppliers such as Factset UK Limited.

Follow us